Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Zhejiang Hisun Pharma Invests in US Biotech Startup

publication date: Mar 25, 2011
Zhejiang Hisun Pharma will invest $6 million in Photolitec LLC, a brand new cancer startup located in Buffalo, NY. Hisun committed to sending Photolitec $2 million immediately and $1 million each year for the next four years, plus milestones. The deal gives Hisun right of first refusal for compounds being developed in conjunction with Photolitec’s Photodynamic Therapy for oncology. More details....

Stock Symbol: (SHA: 600267)     Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital